Literature DB >> 32535134

Asthma-like symptoms in young children increase the risk of COPD.

Hans Bisgaard1, Sarah Nørgaard2, Astrid Sevelsted2, Bo Lund Chawes2, Jakob Stokholm2, Erik Lykke Mortensen3, Charlotte Suppli Ulrik4, Klaus Bønnelykke2.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) may originate in early life and share disease mechanisms with asthma-like symptoms in early childhood. This possibility remains unexplored on account of the lack of long-term prospective studies from infancy to the onset of COPD.
OBJECTIVE: We aimed to investigate the relationship between asthma-like symptoms in young children and development of COPD.
METHODS: In a population-based cohort of women who gave birth at the central hospital in Copenhagen during period from 1959 to 1961, we investigated data from 3290 mother-child pairs who attended examinations during pregnancy and when the children were aged 1, 3, and 6 years. COPD was assessed from the Danish national registries on hospitalizations and prescription medication since 1994. A subgroup of 930 individuals underwent spirometry testing at age 50 years.
RESULTS: Of the 3290 children, 1 in 4 had a history of asthma-like symptoms in early childhood. The adjusted hazard ratio for hospitalization for COPD was 1.88 (95% CI = 1.32-2.68), and the odds ratio for prescription of long-acting muscarinic antagonists was 2.27 (95% CI = 1.38-3.70). Asthma-like symptoms in early childhood were also associated with a reduced FEV1 percent predicted and an FEV1-to-forced vital capacity ratio at age 50 years (-3.36% [95% CI = -5.47 to -1.24] and -1.28 [95% CI = -2.17 to -0.38], respectively) and with COPD defined according to Global Initiative for Chronic Obstructive Lung Disease stage higher than 1 (odds ratio = 1.96 [95% CI = 1.13-3.34]).
CONCLUSION: This 60-year prospective follow-up of a mother-child cohort demonstrated a doubled risk for COPD from childhood asthma-like symptoms.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Asthma; COPD; cohort study

Year:  2020        PMID: 32535134     DOI: 10.1016/j.jaci.2020.05.043

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  5 in total

1.  European Respiratory Society International Congress 2020: highlights from best-abstract awardees.

Authors:  Noel Britton; Amany F Elbehairy; Sara M Mensink-Bout; Astrid Blondeel; Yuanling Liu; Joana Cruz; Jana De Brandt
Journal:  Breathe (Sheff)       Date:  2020-12

2.  Palivizumab immunoprophylaxis for infants with BPD has medium- and long-term benefits: myth or maxim?

Authors:  Lauren A Quinn; Sunaya H Hirani; Thomas C Williams; Ian P Sinha
Journal:  Breathe (Sheff)       Date:  2021-12

3.  Effect of Carbon Black Nanoparticle on Neonatal Lymphoid Tissues Depending on the Gestational Period of Exposure in Mice.

Authors:  Atsuto Onoda; Saki Okamoto; Ryuhei Shimizu; Yasser S El-Sayed; Shiho Watanabe; Shuhei Ogawa; Ryo Abe; Masao Kamimura; Kohei Soga; Ken Tachibana; Ken Takeda; Masakazu Umezawa
Journal:  Front Toxicol       Date:  2021-08-11

Review 4.  Novel Lung Growth Strategy with Biological Therapy Targeting Airway Remodeling in Childhood Bronchial Asthma.

Authors:  Mitsuru Tsuge; Masanori Ikeda; Hirokazu Tsukahara
Journal:  Children (Basel)       Date:  2022-08-19

Review 5.  Adverse early-life environmental exposures and their repercussions on adult respiratory health.

Authors:  Helena Teresinha Mocelin; Gilberto Bueno Fischer; Andrew Bush
Journal:  J Pediatr (Rio J)       Date:  2021-12-16       Impact factor: 2.990

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.